Post on 18-Nov-2014
description
Presented By,Group No-01Animesh Amal (01)Madhura Jagtap (10)Bosco James (15)Shafaatali (18)Bhavika Sachdev (23)
Contents• Mission & Vision• Novartis India• History• People• Top 10 Brands• Current Alliance• Product Mix• Presence• Financial Data• Stock Price• R & D• References
Mission & Vision
• We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
• We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.
Novartis India
Mission Innovative products, Outstanding performance, Ideas and
work.
Vision A better today and tomorrow for patients.
Directors Christopher Snook (Chairman) Ranjit Shahani (Vice Chairman & M.D.)
History
1996 – The shareholders of Sandoz and Ciba-Geigy approve of the merger.
1997- Novartis announces to acquire crop protection business of Merck & co.
2000 - Novartis seeds are merged with Astrazeneca’s agribusiness operations to form Syngenta.
2001- FDI grants approval of Glivec.2003- Novartis unites it’s generics business
under one single global brand - Sandoz.
History of Novartis195819701996Present
People
Full-time associates 2012 total: 127 724
Associates by region, 2012
Top 10 Brands of Novartis India
Current Alliance of Novartis
current-alliances.pdf
Product Mix
Product Mix Width
Pharmaceuticals
Alcon (Eye Care)
Sandoz(Generics)
Over The Counter
Vaccines and Diagnostics
Animal Health
Pharmaceuticals Autoinflammatory and Autoimmune Disease
Ilaris
Hypertension Amturnide, Diovan, Exforge, Lotrel
Metabolism Cubicin, Tyzeka / Sebivo
Neuroscience Clozaril, Comtan, Extavia, Fanapt
Oncology Exjade, Femara, Tasigna, Gleevec
Ophthalmology Lucentis
Respiratory Foradil, Xolair, TOBI, Arcapta Neohaler
Transplantation Myfortic, Simulect, Neoral, Zortress
Virology/ Anti – invectives Cubicin, Tyzeka / Sebivo
Other Lamisil, Famvir, Riamet, Voltaren, Reclast
Alcon (Eye Care)
Surgical Infiniti , Constellation, intraocular lenses ,
Ophthalmic Pharmaceuticals Travatan, Moxeza, Pataday, Nevanac
Vision Care Air Optix brand of breathable contact lenses, Dailies, FreshLook colored lenses
Sandoz(Generics)Anti-coagulant Lovenox®
Anti-infective Augmentin®
Respiratory system Fluimucil®Hypertension Lotrelc®Analgesic Duragesic®Proton pump inhibitor Prevacid®Ulcer & heartburn treatment Prilosec®Cholesterol lowering treatment Zocor®Transplantation Prograf®
OTCNasal decongestant Otrivin
Paediatric nasal decongestant ProRhinel
Cough suppressant Sinecod
Antihistamine Tavegyl/Tavist
Cough and cold treatment Theraflu
Paediatric cough and cold treatment Triaminic
Cough/ Cold/ Respiratory
Contd……Fiber supplement Benefiber
Laxative Ex-Lax
Gas reliever Gas-X
Antacid Maalox
Frequent heartburn treatment Prevacid24HR
Digestive Health
Contd……Pain reliever Excedrin
Anti-inflammatory Voltaren
Calcium supplement CalSource
Skin irritation treatment Fenistil
Antifungal treatment Lamisil
Smoking cessation treatment Nicotinell/Thrive/Habitrol
Systemic antivaricose treatment Venoruton
Pain and Others
Vaccines and Diagnostics Seasonal flu (influenza) Agrippal, Begrivac, Optaflu, Fluad, Fluvirin
H1N1 Focetria
meningococcal disease Menveo
meningitis Menjugate
stimulating the body's immune response
IXIARO
Tickborne encephalitis Encepur N
Rabies prevention RabAvert
Diphtheria Quinvaxem
poliovirus type 1, 2 and 3 Polioral
Animal HealthPet Health Atopica, Capstar, Deramaxx , Fortekor,
Interceptor, Milbemax, Milbemax, Prac-tic, Sentinel
Livestock Acatak Duostar, CLiK, Denagard, Fasinex, Vira Shield , ZOLVIX
Bioprotection Agita 10WG, Larvadex, Neporex, Oxyfly, Ratsnip, Spy, Virusnip
PresenceNorwayPhilippinesPolandPortugalRussiaSlovakiaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUSAVenezuela
FinlandFranceGermanyGreeceHong KongHungaryIndiaIndonesiaItalyJapanKoreaMexico
ArgentinaAustraliaAustriaBangladeshBelgiumBrazilCanadaChileChinaColombiaDenmarkEgyptNorway
Pharmaceuticals
Alcon Sandoz Vaccines and Diagnostics
Consumer Health
United States 32% 10 392 39% 4 016 32% 2 786 40% 746 17% 652
Europe 32% 10 238 27% 2 710 49% 4 225 35% 658 50% 1 877
Asia/Africa/ Australasia
26% 8 434 23% 2 395 12% 1 057 15% 273 21% 777
Canada and Latin America
10% 3 089 11% 1 104 7% 634 10% 181 12% 429
Total 32 153 10 225 8 702 1 858 3 735
Established Markets
77% 24 778 76% 7 805 74% 6 402 77% 1 434 65% 2 415
Emerging Growth Markets
23% 7 375 24% 2 420 26% 2 300 23% 424 35% 1 320
Total 32 153 10 225 8 702 1 858 3 735
2012 NET SALES BY REGION AND SEGMENT
2012 NET SALES BY SEGMENT
% USD in millions
Pharmaceuticals 57 32 153
Alcon 18 10 225
Sandoz 15 8 702
Vaccines and Diagnostics 3 1858
Consumer Health 7 3735
Total 56 673
Pharmaceuticals :- Sales : Rs. 330.5 Cr. (Half year ended September 2012) Growth : 11.8% OTC :- Sales : Rs. 48.2 cr. (Half year ended September 2012) Growth : - 10.07% Animal Health :- Sales : Rs. 47.6 Cr. (Half year ended September 2012) Growth : 16.95%
Sandoz(Generics):- Sales : Rs. 30.6 Cr. (Half year ended September 2012) Growth : 5.15%
Net sales (India)
Stock Price of NovartisBSE:500672
BSE 590.00 4.05 (+0.69%)VOLUME 42,989 PREV. CLOSE 585.95OPEN PRICE 587.95BID PRICE (QTY.) 590.00 (1,510)OFFER PRICE (QTY.) 0.00 (0)YESTERDAY'S LOW/HIGH 583.10 594.0052 WK LOW/HIGH 574.00 934.20
(as per 14/3/13 data)
ROLE OF R&D
• Targeting rare and neglected diseases• Ethical research• Responsible R&D
R&D LOCATIONS OF NOVARTIS
• NIBR PHARMA DEVELOPMENT -EMERYVILLE US -INDIA -LA JOLLA CALIFORNIA US -CHINA - FORT WORTH TX USA -JAPAN -CAMBRIDGE US -EAST HANOVER US
-HORSHAM UK VACCINES AND DIAGNOSTIC -BASEL SWITZERLAND -US -SIENA ITALY -ITALY -SINGAPORE -SHANGHAI CHINA
References
• Balance Sheet (2012) of Novartis• http://
www.fiercebiotech.com/story/novartis-lists-its-top-blockbuster-prospects-11-15/2011-07-19
• http://management.fortune.cnn.com/tag/blockbuster-drugs/
• http://www.novartis.com/• http://
www.novartis.com/products/pharmaceuticals-therapeutic-area.shtml
• http://www.novartis.com/products/index.shtml